G
GenZum Life Sciences
Globally integrated generic pharmaceutical product development and out-licensing company, based in los angeles
About GenZum Life Sciences
GenZum Life Sciences operates as a globally integrated pharmaceutical company with a focus on product development and out-licensing. The company specializes in the development of high-barrier and complex generic drugs, with a particular emphasis on semi-solid and ophthalmic formulations.
GenZum's business model covers the entire product development cycle, from initial product selection and formulation to conducting clinical trials and navigating the FDA approval process. By concentrating on high-barrier and complex generics, the company targets niche markets with less competition. The out-licensing model allows GenZum to generate revenue by partnering with larger pharmaceutical companies for the commercialization of its developed products.
The company's primary clients are other pharmaceutical firms that seek to expand their product portfolios with specialized generic drugs. GenZum operates in the global pharmaceutical market, with a focus on regulated markets such as the United States. The company was founded in 2005 and is privately held.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Beverly Hills, United States
- Employees
- 2
- Open positions
- None listed
- Dealroom signal
- 23.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jun 2014 | $20M | $80M | Group 11 | — |
Growth signals
Latest recorded traffic for GenZum Life Sciences is 110 monthly website visits, down 8.3% over the last three months. GenZum Life Sciences's team declined 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GenZum Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GenZum Life Sciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.